FDA Inspection 970700 — Oklahoma Blood Institute East Central

Oklahoma Blood Institute East Central — FEI 1641495

The FDA completed an inspection of Oklahoma Blood Institute East Central on March 16, 2016 in Ada, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 16, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ada, OK (United States)